Raheleh Ganjali1, Mahin Ghorban Sabbagh2,3, Fatemeh Nazemiyan2,4, Fereshteh Mamdouhi2,3, Shapour Badiee Aval5, Zhila Taherzadeh6, Fatemeh Heshmati Nabavi7, Reza Golmakani8, Fariba Tohidinezhad1, Saeid Eslami1,9,10. 1. Department of Medical Informatics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. 2. Kidney Transplantation Complications Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. 3. Department of Nephrology, Montaseriyeh Organ Transplantation Hospital, Mashhad University of Medical Sciences, Mashhad, Iran. 4. Department of Nephrology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran. 5. Complementary Medicine Research Center, Faculty of Traditional Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. 6. Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. 7. School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran. 8. Department of Emergency Medicine, Doctor Shariati Hospital, Mashhad University of Medical Sciences, Mashhad, Iran. 9. Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. 10. Department of Medical Informatics, University of Amsterdam, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Medication non-adherence is the major risk factor for rejection episodes. The aim of this study was to determine the risk factors associated with adherence to immunosuppressive regimen and its barriers among kidney transplant (KT) recipients. METHODS: A cross-sectional study was performed in two outpatient post-transplant clinics in Mashhad, northeast of Iran. All patients who attended the clinics from August to October 2017 were included. Patients's knowledge, adherence to immunosuppressive regimen, and quality of life were measured using the Kidney Transplant Understanding Tool, Basel Assessment of Adherence to Immunosuppressive Medications Scale (BAASIS), and SF-12V2 questionnaire, respectively. The barriers in adhering immunosuppressive regimen were investigated by Immunosuppressive Therapy Barriers Scale. Logistic regression was used to screen the significant risk factors of medication non-adherence. RESULTS: In this study, 244 KT recipients were included with a mean age of 39.6±12.5 years. Based on the BAASIS score, 111 (45.5%) patients were adherent to immunosuppressive regimen. Female patients were more likely to be adherent (OR=0.48, p<0.01). The patients with higher level of quality of life were more likely to follow immunosuppressive medications (OR=1.078, p<0.05). The main barriers were as follows: concurrent use of many immunosuppressants, lack of knowledge about the usefulness of immunosuppressive medications, confusion in medication taking, and difficulty in remembering medication taking. CONCLUSION: More than half of the KT recipients were non-adherence to immunosuppressive regimen. These findings highlight the need for designing interventions in order to reduce or eliminate these barriers and consequently increase medication adherence among KT recipients.
BACKGROUND: Medication non-adherence is the major risk factor for rejection episodes. The aim of this study was to determine the risk factors associated with adherence to immunosuppressive regimen and its barriers among kidney transplant (KT) recipients. METHODS: A cross-sectional study was performed in two outpatient post-transplant clinics in Mashhad, northeast of Iran. All patients who attended the clinics from August to October 2017 were included. Patients's knowledge, adherence to immunosuppressive regimen, and quality of life were measured using the Kidney Transplant Understanding Tool, Basel Assessment of Adherence to Immunosuppressive Medications Scale (BAASIS), and SF-12V2 questionnaire, respectively. The barriers in adhering immunosuppressive regimen were investigated by Immunosuppressive Therapy Barriers Scale. Logistic regression was used to screen the significant risk factors of medication non-adherence. RESULTS: In this study, 244 KT recipients were included with a mean age of 39.6±12.5 years. Based on the BAASIS score, 111 (45.5%) patients were adherent to immunosuppressive regimen. Female patients were more likely to be adherent (OR=0.48, p<0.01). The patients with higher level of quality of life were more likely to follow immunosuppressive medications (OR=1.078, p<0.05). The main barriers were as follows: concurrent use of many immunosuppressants, lack of knowledge about the usefulness of immunosuppressive medications, confusion in medication taking, and difficulty in remembering medication taking. CONCLUSION: More than half of the KT recipients were non-adherence to immunosuppressive regimen. These findings highlight the need for designing interventions in order to reduce or eliminate these barriers and consequently increase medication adherence among KT recipients.
Authors: Amelia Rose Cossart; Christine Elizabeth Staatz; Scott Bryan Campbell; Nicole Maree Isbel; William Neil Cottrell Journal: Nephrology (Carlton) Date: 2019-01 Impact factor: 2.506
Authors: Cynthia L Russell; Catherine Ashbaugh; Leanne Peace; Muammer Cetingok; Karen Q Hamburger; Sarah Owens; Deanna Coffey; Andrew W Webb; Donna Hathaway; Rebecca P Winsett; Richard Madsen; Mark R Wakefield Journal: Clin Transplant Date: 2013 Sep-Oct Impact factor: 2.863
Authors: Marie A Chisholm-Burns; Christina A Spivey; Elizabeth A Tolley; Erin K Kaplan Journal: Patient Prefer Adherence Date: 2016-04-28 Impact factor: 2.711